Back to Search
Start Over
New Findings on COVID-19 Described by Investigators at Saint Luke's Mid America Heart Institute [Dapagliflozin In Patients With Cardiometabolic Risk Factors Hospitalised With Covid-19 (Dare-19): a Randomised, Double-blind, Placebo-controlled, ...]
- Source :
- Medical Letter on the CDC & FDA. October 24, 2021, 447
- Publication Year :
- 2021
-
Abstract
- 2021 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Fresh data on Coronavirus - COVID-19 are presented in a [...]
Details
- Language :
- English
- ISSN :
- 15324648
- Database :
- Gale General OneFile
- Journal :
- Medical Letter on the CDC & FDA
- Publication Type :
- News
- Accession number :
- edsgcl.679231070